Costs of intravenous adverse drug events in academic and nonacademic intensive care units

Medical Care

Volumn 46, Issue 1, 2008, Pages 17-24

  Nuckols, Teryl K ^a,b   Paddock, Susan M ^a   Bower, Anthony G ^c   Rothschild, Jeffrey M ^d   Fairbanks, Rollin J ^e   Carlson, Beverly ^f   Panzer, Robert J ^e   Hilborne, Lee H ^b  

^a RAND CORPORATION   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMGEN INC   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e UNIVERSITY OF ROCHESTER   (United States)

^f SHARP HEALTHCARE   (United States)

Author keywords

Critical care; Drug therapy: adverse effects; Economics; Intravenous infusions; Intravenous injections

Indexed keywords

DRUG;

AGED; APACHE; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COMPARATIVE STUDY; ECONOMICS; FEMALE; HEALTH ECONOMICS; HUMAN; INTENSIVE CARE UNIT; INTRAVENOUS DRUG ADMINISTRATION; LENGTH OF STAY; MALE; MEDICATION ERROR; MIDDLE AGED; MULTICENTER STUDY; TEACHING HOSPITAL; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; AGED; APACHE; CASE-CONTROL STUDIES; ECONOMICS, HOSPITAL; FEMALE; HOSPITALS, TEACHING; HUMANS; INFUSIONS, INTRAVENOUS; INJECTIONS, INTRAVENOUS; INTENSIVE CARE UNITS; LENGTH OF STAY; MALE; MEDICATION ERRORS; MIDDLE AGED; PHARMACEUTICAL PREPARATIONS;

EID: 37649010513     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/MLR.0b013e3181589bed     Document Type: Article

References (33)

1. Rothschild JM, Landrigan CP, Cronin JW, et al. The Critical Care Safety Study: the incidence and nature of adverse events and serious medical errors in intensive care. Crit Care Med. 2005;33:1694-1700.
2. Bates DW, Spell N, Cullen DJ, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307-311.
3. Committee on Identifying and Preventing Medication Errors. Aspden P, Wolcott J, Bootman JL, et al, eds. Preventing Medication Errors: Quality Chasm Series. Washington, DC: Institute of Medicine of the National Academies. Available at: http://www.nap.edu/catalog/11623.html. Anticipated. 2007. Republication copy accessed. October 19, 2006.
4. Yuan Z, Cooper GS, Einstadter D, et al. The association between hospital type and mortality and length of stay: a study of 16. 9 million hospitalized Medicare beneficiaries. Med Care. 2000;38:231-245.
5. Rothschild JM, Federico FA, Gandhi TK, et al. Analysis of medicationrelated malpractice claims: causes, preventability, and costs. Arch Intern Med. 2002;162:2414-2420.
6. Localio AR, Lawthers AG, Brennan TA, et al. Relation between malpractice claims and adverse events due to negligence. Results of the Harvard Medical Practice Study III. N Engl J Med. 1991;325:245-251.
7. Brennan TA, Sox CM, Burstin HR. Relation between negligent adverse events and the outcomes of medical-malpractice litigation. N Engl J Med. 1996;335:1963-1967.
8. Greengold NL, Shane R, Schneider P, et al. The impact of dedicated medication nurses on the medication administration error rate: a randomized controlled trial. Arch Intern Med. 2003;163:2359-2367.
9. Wright AA, Katz IT. Bar coding for patient safety. N Engl J Med. 2005;353:329-331.
10. Rothschild. JM, Keohane CA, Cook EF, et al. A controlled, trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med. 2005;33:533-540.
11. Malashock CM, Shull SS, Gould DA. Effect of smart infusion pumps on medication errors related to infusion device programming. Hosp Pharm. 2004;39:460-469.
12. Council of Teaching Hospitals and Health Systems (COTH). Member Teaching Hospitals and Health Systems. Available at: http://www.aamc.org/ members/coth/. Accessed March 23, 2007.
13. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
14. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
15. Rozich JD, Haraden CR, Resar RK. Adverse drug event trigger tool: a practical methodology for measuring medication related harm. Qual Saf Health Care. 2003;12:194-200.
16. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events: implications for prevention. JAMA. 1995;274:29-34.
17. National Coordinating Council for Medication Error Reporting and Prevention. Taxonomy of Medication Errors. 1998. Available at: http://www.nccmerp.org/pdf/taxo2001-07-31.pdf. Accessed December 1, 2005.
18. Dubois RW, Brook RH. Preventable deaths: who, how often, and why? Ann Intern Med. 1988;109:582-589.
19. Rosenbaum PR. Optimal matching for observational studies. JASA. 1989;84:1024-1032.
20. Bergstralh EJ, Kosanke JL. Computerized Matching of Controls. Rochester, MN: Mayo Foundation; 1995. Mayo Foundation Section of Biostatistics Technical Report No. 56.
21. McCaffrey D, Ridgeway G, Morral A. Propensity score estimation with boosted regression for evaluating adolescent substance abuse treatment. Psychol Meth. 2004;9:403-425.
22. U.S. Census Bureau. U.S. Census 2000: Summary File 3. 2002. Extracted, by CensusWork.com in August 2003.
23. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70:41-55.
24. Fiscella K, Franks P. Impact of patient socioeconomic status on physi cian profiles: a comparison of census-derived and individual measures. Med Care. 2001;39:8-14.
25. SAS Institute. The SAS System for Windows. SAS Version 9.1.3. Cary, NC: SAS Institute, Inc.; 2005.
26. Cullen DJ, Sweitzer BJ, Bates DW, et al. Preventable adverse drug events in hospitalized patients: a comparative study of intensive care and general care units. Crit Care Med. 1997;25:1289-1297.
27. Classen DC, Pestotnik SL, Evans RS, et al. Adverse drug events in hospitalized patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1997;277:301-306.
28. U.S. Department of Labor, Bureau of Labor Statistics. Consumer price index, all urban consumers. Available at: http://data.bls.gov. Accessed October 19, 2006.
29. The Lewin Group. Utilization and volume. In: TrendWatch Chartbook 2006, Trends Affecting Hospitals and Health Systems. Prepared by The Lewin Group, Inc. for The American Hospital Association. Falls Church, VA: The Lewin Group, Inc.; 2006. (Available at):http://www.aha.org/aha/research-and-trends/ health-and-hospital-trends/2006.html. Accessed October 19, 2006.
30. Thornlow DK, Stukenborg GJ. The association between hospital characteristics and rates of preventable complications and adverse events. Med Care. 2006;44:265-269.
31. Brennan TA, Hebert LE, Laird NM, et al. Hospital characteristics associated with adverse events and substandard care. JAMA. 1991;265: 3265-3269.
32. Leape LL, Cullen DJ, Clapp MD, et al. Pharmacist participation on physician rounds and adverse drug events in the intensive care unit. JAMA. 1999;282:267-270.
33. Bates DW, Teich JM, Lee J, et al. The impact of computerized physician order entry on medication error prevention. J Am Med Inform Assoc. 1999;6:313-321.